Top Page
Eden Innovations
(Sydney:EDE)
Eden Innovations (EDE) vs. iShares MSCI Australia ETF (EWA)
Eden Innovations Business Overview & Revenue Model
Eden Innovations Financial Statement Overview
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.02M | 4.70M | 4.15M | 3.28M | 2.43M |
| Gross Profit | 1.39M | -2.17M | -3.36M | -3.10M | -4.90M |
| EBITDA | -4.83M | -15.08M | -4.49M | -3.73M | -7.37M |
| Net Income | -7.55M | -17.87M | -6.65M | -5.76M | -9.11M |
Balance Sheet | |||||
| Total Assets | 19.07M | 17.00M | 25.79M | 24.48M | 22.81M |
| Cash, Cash Equivalents and Short-Term Investments | 975.20K | 2.53M | 1.55M | 2.18M | 1.39M |
| Total Debt | 12.79M | 10.21M | 4.91M | 5.26M | 6.00M |
| Total Liabilities | 15.10M | 12.28M | 6.30M | 6.34M | 7.07M |
| Stockholders Equity | 3.98M | 4.73M | 19.49M | 18.14M | 15.73M |
Cash Flow | |||||
| Free Cash Flow | -5.27M | -5.11M | -7.51M | -7.46M | -9.65M |
| Operating Cash Flow | -5.22M | -4.17M | -6.03M | -5.55M | -7.38M |
| Investing Cash Flow | -586.79K | -940.93K | -1.48M | -1.91M | -2.28M |
| Financing Cash Flow | 4.26M | 6.09M | 6.78M | 8.45M | 7.85M |
Eden Innovations Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | AU$11.51M | 11.90 | 9.53% | ― | 11.60% | ― | |
66 Neutral | £2.68B | 13.00 | 3.30% | 3.25% | 2.40% | -22.21% | |
57 Neutral | AU$23.43M | 22.95 | 5.21% | 2.86% | 37.72% | -4.69% | |
53 Neutral | AU$34.24M | ― | -11.18% | ― | -0.46% | -323.61% | |
43 Neutral | AU$13.88M | ― | -1011.73% | ― | ― | ― | |
31 Underperform | $13.27M | ― | -150.37% | ― | -1.30% | 31.85% | |
27 Underperform | AU$11.88M | ― | -122.51% | ― | ― | 26.32% |
Eden Innovations Corporate Events
Eden Innovations Ltd reported significant sales growth for the quarter ending June 2025, with the second-highest quarterly sales recorded at US$360k. The company achieved a 114% year-on-year increase in Q4 sales for EdenCrete® products and a 50% increase in total sales for FY25 compared to FY24. Notably, the Pz7 ‘Ready Mix Concrete’ Plant installations expanded rapidly, with 12 new installations in Q4, increasing the total to 16 plants across the USA and Ecuador. Additionally, Eden Innovations is strengthening its balance sheet through substantial debt repayments and a capital raising initiative, including a US$5m property sale in Georgia to reduce borrowing costs and support the global rollout of its products.
Eden Innovations Ltd announced the successful passing of three resolutions at its General Meeting, which include the consolidation of capital and the approval of issuing securities to convert debt into equity for March Bells Pty Ltd and Arkenstone Pty Ltd. This strategic move is expected to strengthen the company’s financial position by reducing debt and potentially enhancing shareholder value, reflecting positively on its market positioning.
Eden Innovations Ltd has announced an update regarding the sale of its 65.58-acre industrial property in Augusta, Georgia, USA. The purchaser, JB2 Partners LLC, has exercised its eighth option to extend the inspection period by an additional 30 days, with the new deadline set for August 13, 2025. The extension involves a fee of $50,000, which will be allocated towards interest reserve and a fee to iBorrow. This development indicates ongoing negotiations and adjustments in the property sale process, which Eden will continue to monitor and report to its shareholders.
Eden Innovations Ltd has announced the increasing use of its EdenCrete® products in significant projects in Denver, Colorado. These projects include a 22-story high-rise building, public swimming pools, and a major highway upgrade, highlighting the growing adoption of EdenCrete® in diverse applications. The involvement in these projects, particularly the US$900 million Interstate Highway 70 upgrade, underscores Eden’s expanding footprint in the construction sector and its potential impact on the company’s market positioning.
Eden Innovations Ltd has announced the anticipated settlement of a 65-acre industrial property sale in Augusta, Georgia, for US$5 million, expected to occur on 25 August 2025. The proceeds from this sale will significantly reduce the company’s debt by approximately 70%, lowering its monthly interest and borrowing costs. The sale is contingent upon the final permitting approval for the proposed development, which has received strong support from local Augusta authorities. The successful completion of this transaction is expected to enhance Eden’s financial position and operational focus.
Eden Innovations Ltd has announced a General Meeting of shareholders to be held on July 22, 2025, in Perth, Australia. The meeting’s agenda includes resolutions for the consolidation of the company’s capital and the approval of issuing securities to convert debt into equity. The consolidation will involve converting every twenty shares into one share, and adjusting existing options accordingly. Additionally, the company seeks approval to issue shares and options to March Bells Pty Ltd and Arkenstone Pty Ltd, entities associated with the Solomon family trusts, as partial repayment of loans. These resolutions aim to streamline the company’s capital structure and manage its debt obligations.
Eden Innovations Ltd announced a proposed issue of securities, including 61,750,000 unlisted options and 123,500,000 ordinary fully paid shares, with a proposed issue date of July 23, 2025. This move is part of the company’s strategy to raise capital, potentially enhancing its market position and providing financial resources for future growth and development, which could have significant implications for its stakeholders.
Eden Innovations Ltd has announced a security consolidation affecting its ordinary fully paid shares and options expiring in September 2026. This reorganization is set to commence trading on a deferred settlement basis by the end of July 2025, with the record date on August 1, 2025, and issue date on August 8, 2025. The consolidation, which has received estimated approval from security holders, is expected to streamline the company’s securities and potentially enhance market perception and investor interest.
Eden Innovations Ltd has announced a strategic financial restructuring plan that includes a renounceable pro-rata shareholder rights offer and a share issue aimed at significantly reducing its debt and providing working capital for its product lines EdenCrete® and OptiBlend®. The company is also proposing a security consolidation to streamline its capital structure, subject to shareholder approval at a general meeting scheduled for July 22, 2025. This move is expected to enhance Eden’s operational efficiency and strengthen its market position, potentially benefiting stakeholders through improved financial health and continued product commercialization.
Eden Innovations Ltd announced that JB2 Partners LLC has exercised its seventh option to extend the inspection period for the purchase of a 65.58-acre industrial property in Augusta, Georgia. The extension, which lasts until July 14, 2025, involves a US$50,000 fee applied towards the interest reserve, indicating ongoing negotiations and potential future developments in the company’s real estate dealings.
Eden Innovations Ltd has reported significant growth in sales of its EdenCrete® products, with total sales reaching US$567,759 between February and May 2025. This marks an 86% increase in year-on-year sales for April and May compared to the same period in the previous year. The company has also expanded its international presence, with installations of EdenCrete® Pz7 systems in 16 ready-mix concrete plants, primarily in Ecuador and the Denver area of Colorado. This expansion highlights Eden Innovations’ strengthening position in the global market for advanced concrete solutions.
Eden Innovations Ltd has announced an update on the sale of its 65.58-acre industrial property in Augusta, Georgia, USA. The purchaser, JB2 Partners LLC, has exercised its sixth option to extend the inspection period by an additional 30 days, with an extension fee of US$50,000 being applied towards the interest reserve. This development indicates ongoing negotiations and due diligence in the transaction, which Eden will continue to update its shareholders on.
Eden Innovations Ltd has announced its first order from Holcim Mexico for its product EdenCretePz7, marking a strategic entry into the Mexican market. This development follows extensive testing and is part of a broader rollout by Holcim Group, which is now using EdenCretePz7 in the USA, Ecuador, and Mexico. Although the initial order is small, it signifies potential growth and increased adoption of EdenCretePz7 in the concrete industry, enhancing Eden Innovations’ market positioning and offering promising implications for stakeholders.